Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct;35(5):406-419.
doi: 10.1521/aeap.2023.35.5.406.

Navigating the Viral Divide: Sexual and Gender Minority Community Perspectives on Treatment as Prevention

Affiliations

Navigating the Viral Divide: Sexual and Gender Minority Community Perspectives on Treatment as Prevention

Alexander Borsa et al. AIDS Educ Prev. 2023 Oct.

Abstract

Since it was established that HIV-positive individuals who maintain an undetectable viral load are unable to sexually transmit HIV (U=U), treatment as prevention (TasP) has become an important biomedical HIV prevention option. Many have remained optimistic that TasP, combined with pre-exposure prophylaxis (PrEP), will help close the "viral divide" between those living with and without HIV. This qualitative interview study of 62 sexual and gender minority (SGM) individuals of mixed serostatuses explored community perspectives regarding TasP, including the meaning of undetectability and how U=U impacts understandings of serodifference. Five key themes emerged from interviews: (1) undetectable does not equal HIV-negative, (2) PrEP is more promoted than TasP, (3) TasP increases openness to serodifferent sex, (4) rejection of TasP absolutism, and (5) the importance of layering prevention strategies. These findings suggest that while TasP is helping to bridge the viral divide, serostatus distinctions remain prevalent and important to many SGM individuals.

Keywords: PrEP; SGM; TasP; U=U; serodifference.

PubMed Disclaimer

Conflict of interest statement

Declaration of interest. A.B. works part-time as a scientific advisor for IQVIA.

Similar articles

Cited by

References

    1. Bavinton BR, Pinto AN, Phanuphak N, Grinsztejn B, Prestage GP, Zablotska-Manos IB, Jin F, Fairley CK, Moore R, Roth N, Bloch M, Pell C, McNulty AM, Baker D, Hoy J, Tee BK, Templeton DJ, Cooper DA, Emery S, … Pinto AN (2018). Viral suppression and HIV transmission in serodiscordant male couples: An international, prospective, observational, cohort study. The Lancet HIV, 5(8), e438–447. 10.1016/S2352-3018(18)30132-2 - DOI - PubMed
    1. Bond KT, Chandler R, Chapman-Lambert C, Jemmott LS, Lanier Y, Cao J, Nikpour J, & Randolph SD (2021). Applying a nursing perspective to address the challenges experienced by cisgender women in the HIV Status Neutral Care Continuum: A review of the literature. Journal of the Association of Nurses in AIDS Care, 32(3), 283–305. 10.1097/JNC.0000000000000243 - DOI - PMC - PubMed
    1. Brown G, Leonard W, Lyons A, Power J, Sander D, McColl W, Johnson R, James C, Hodson M, & Carman M (2017). Stigma, gay men and biomedical prevention: The challenges and opportunities of a rapidly changing HIV prevention landscape. Sexual Health, 14(1), 111. 10.1071/SH16052 - DOI - PubMed
    1. Cahill S, Taylor SW, Elsesser SA, Mena L, Hickson D, & Mayer KH (2017). Stigma, medical mistrust, and perceived racism may affect PrEP awareness and uptake in Black compared to White gay and bisexual men in Jackson, Mississippi and Boston, Massachusetts. AIDS Care, 29(11), 1351–1358. 10.1080/09540121.2017.1300633 - DOI - PMC - PubMed
    1. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JHS, Godbole SV, Chariyalertsak S, Santos BR, Mayer KH, Hoffman IF, Eshleman SH, Piwowar-Manning E, Cottle L, Zhang XC, … HPTN 052 Study Team. (2016). Antiretroviral therapy for the prevention of HIV-1 transmission. New England Journal of Medicine, 375(9), 830–839. 10.1056/NEJMoa1600693 - DOI - PMC - PubMed

Publication types

LinkOut - more resources